Clinical Trial Update: Study for the Treatment of Ocular Chronic Graft-Versus-Host Disease (GVHD) With Amniotic Fluid Eye Drops (AFED) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating amniotic fluid eye drops for ocular graft-versus-host disease has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Graft-versus-host Disease

Drugs mentioned

• Amniotic Fluid Eye Drops (AFED) (amniotic fluid eye drops)

Snippet

Sponsor: University of Utah | Conditions: Ocular Graft Versus Host Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-09